title: 5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
authors.forename: Daniele
authors.initials: D
authors.lastname: Focosi
authors.forename: Richard Eric
authors.initials: RE
authors.lastname: Kast
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Maggi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Lauria
authors.forename: Luca
authors.initials: L
authors.lastname: Ceccherini-Nelli
authors.forename: Mario
authors.initials: M
authors.lastname: Petrini
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007577:JC Virus / Q000302:isolation & purification; D007968:Leukoencephalopathy, Progressive Multifocal / Q000150:complications / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D008297:Male; D008803:Mianserin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D000078785:Mirtazapine; D011087:Polycythemia Vera / Q000150:complications / Q000473:pathology; D058830:Serotonin 5-HT2 Receptor Antagonists; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D008803:Mianserin; D000078785:Mirtazapine; D058830:Serotonin 5-HT2 Receptor Antagonists; D017367:Selective Serotonin Reuptake Inhibitors